Low dose amiodarone in refractory tachyarrhythmias. 1992

M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
Department of Cardiology, Institute of Post Graduate Medical Education and Research, Calcutta.

Fifty patients with drug resistant tachyarrhythmias were treated with amiodarone for 6-22 months; 16 for recurrent ventricular tachycardia (VT), 2 for VT followed by ventricular fibrillation (VF), 14 for complex ventricular ectopics, and 18 for supraventricular tachyarrhythmias (SVT). Amiodarone was administered in a dose much lower than that used in western trials. The actual incidence of successful amiodarone therapy was 81.2% at 22 months for patients with VT. Among the patients with SVT, 88.6% patients were successfully treated for 22 months (range 3-22 months). Amiodarone toxicity appeared in 22 of 50 patients (44%) treated for more than 12 weeks. Withdrawal of therapy was required in 4 patients. Despite the lower dose, clinical efficacy and onset of action were comparable to the western experience.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000638 Amiodarone An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance. Amiobeta,Amiodarex,Amiodarona,Amiodarone Hydrochloride,Amiohexal,Aratac,Braxan,Corbionax,Cordarex,Cordarone,Kordaron,L-3428,Ortacrone,Rytmarone,SKF 33134-A,Tachydaron,Trangorex,Hydrochloride, Amiodarone,L 3428,L3428,SKF 33134 A,SKF 33134A
D013614 Tachycardia, Paroxysmal Abnormally rapid heartbeats with sudden onset and cessation. Paroxysmal Reciprocal Tachycardia,Paroxysmal Reciprocal Tachycardias,Paroxysmal Tachycardia,Paroxysmal Tachycardias,Reciprocal Tachycardia, Paroxysmal,Reciprocal Tachycardias, Paroxysmal,Tachycardia, Paroxysmal Reciprocal,Tachycardias, Paroxysmal,Tachycardias, Paroxysmal Reciprocal

Related Publications

M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
December 1990, American heart journal,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
October 1983, American heart journal,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
January 1981, The New Zealand medical journal,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
June 1981, American heart journal,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
June 1983, Circulation,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
May 1989, Cleveland Clinic journal of medicine,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
April 1995, Journal of the American College of Cardiology,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
April 1981, American heart journal,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
July 1988, Pacing and clinical electrophysiology : PACE,
M Panja, and A K Maity, and A K Kar, and S S Chatterjee, and S Kumar, and S Roy, and D P Sinha, and B Majumdar, and S Panja
September 1998, Japanese circulation journal,
Copied contents to your clipboard!